Lead nephropathy: Early leads from descriptive studies

Internal Medicine Journal

Volumn 36, Issue 10, 2006, Pages 678-682

  Chow, K M ^a,b   Liu, Z C ^b   Szeto, C C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Epidemiology; Lead nephropathy; Moonshine; Saturnine gout

Indexed keywords

LEAD; PAINT;

CLINICAL FEATURE; DUST; EPIDEMIC; FOLLOW UP; GOUT; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; LEAD POISONING; OCCUPATIONAL DISEASE; PRIORITY JOURNAL; REVIEW; WATER SUPPLY;

EID: 33748356463     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01181.x     Document Type: Review

References (40)

1. Waldron HA. Lead poisoning in the ancient world. Med Hist 1973; 7: 391-9.
2. Marsden PA. Increased body lead burden - cause or consequence of chronic renal insufficiency? N Engl J Med 2003; 348: 345-7.
3. Bennett WM. Lead nephropathy. Kidney Int 1985; 28: 212-20.
4. Pollock CA, Ibels LS. Lead nephropathy - a preventable cause of renal failure. Int J Artif Organs 1988; 11: 75-8.
5. Grimes DA, Schulz KF. Descriptive studies: what they can and cannot do. Lancet 2002; 359: 145-9.
6. Stolley PD, Lasky T. Investigating Disease Patterns: The Science of Epidemiology. New York: Scientific American Library; 1995.
7. Nriagu JO. Lead exposure and lead poisoning. In: Nriagu JO, ed. Lead and Lead Poisoning in Antiquity. New York: John Wiley & Sons; 1983; 378-424.
8. Weeden RP. The role of lead in renal failure. Clin Exp Dial Apheresis 1982; 6: 113-46.
9. Loghman-Adham M. Renal effects of environmental and occupational lead exposure. Environ Health Perspect 1997; 105: 928-39.
10. Wedeen RP. The 'pisse-prophets'. In: Wedeen RP, ed. Poison in the Pot: The Legacy of Lead. Carbondale: Southern Illinois University Press; 1984; 143-81.
11. Lancereaux E. Néphrite et arthrite saturnines: coïncidence de ces affections: paeallele avec la nephrite et l' arthrite gouteusses. Arch de Générales Médicines 1881; 6: 641-7.
12. Wohl AS. 'The canker of industrial diseases'. In: Wohl AS, ed. Endangered Lives: Public Health in Victorian Britain. Cambridge: Harvard University Press; 1983; 257-84.
13. Oliver T. Lead Poisoning: From the Industrial, Medical and Social Points of View, Lectures Delivered at the Royal Institute of Public Health. London: H. K. Lewis; 1914; 1-294.
14. Lilis R, Gavrilescu N, Nestorescu B, Dumitriu C, Roventa A. Nephropathy in chronic lead poisoning. Br J Ind Med 1968; 25: 196-202.
15. Emmerson BT. Chronic lead nephropathy. Kidney Int 1973; 4: 1-5.
16. Rodin AE, Key JD. Medicine Literature & Eponyms: An Encyclopedia of Medical Eponyms Derived from Literary Characters. Malabar, FL: Robert E. Krieger Publishing Company; 1989.
17. Nye LJ. An investigation of the extraordinary incidence of chronic nephritis in young people in Queensland. Med J Aust 1929; 2: 145-59.
18. Henderson DA. A follow-up of cases of plumbism in children. Australas Ann Med 1954; 3: 219-24.
19. Henderson DA. Chronic nephritis in Queensland. Australas Ann Med 1955; 4: 163-77.
20. Morgan JM, Hartley MW, Miller RE. Nephropathy in chronic lead poisoning. Arch Intern Med 1966; 118: 17-29.
21. Batuman V, Maesaka JK, Haddad B, Tepper E, Landy E, Wedeen RP. The role of lead in gout nephropathy. N Engl J Med 1981; 304: 520-23.
22. Crutcher JC. Clinical manifestations and therapy of acute lead intoxication due to ingestion of illicitly distilled alcohol. Ann Intern Med 1963; 59: 707-15.
23. Klinenberg JR. Saturnine gout - a moonshine malady. N Engl J Med 1969; 280: 1238-9.
24. Halla JT, Ball GV. Saturnine gout: a review of 42 patients. Semin Arthritis Rheum 1982; 11: 307-14.
25. Eskew AE, Crutcher JC, Zimmerman SL, Johnston GW, Butz WC. Lead poisoning resulting from illicit alcohol consumption. J Forensic Sci 1961; 6: 337-50.
26. Owen C Jr, Dodson WH, Hammack WJ. Medical grand rounds from the University of Alabama Medical Center. South Med J 1967; 60: 44-50.
27. Peitzman SJ, Bodison W, Ellis I. Moonshine drinking among hypertensive veterans in Philadelphia. Arch Intern Med 1985; 145: 632-4.
28. Emmerson BT. Chronic lead nephropathy: the diagnostic use of calcium EDTA and the association with gout. Australas Ann Med 1963; 12: 310-24.
29. Colleoni N, D'Amico G. Chronic lead accumulation as a possible cause of renal failure in gouty patients. Nephron 1986; 44: 32-5.
30. Brewster UC, Perazella MA. A review of chronic lead intoxication: an unrecognized cause of chronic kidney disease. Am J Med Sci 2004; 327: 341-7.
31. Burry AF. A profile of renal disease in Queensland: results of an autopsy survey. Med J Aust 1966; 1: 826-34.
32. Henderson DA, Inglis JA. The lead content of bone in chronic Bright's disease. Australas Ann Med 1957; 6: 145-54.
33. Cooper WC, Gaffey WR. Mortality of lead workers. J Occup Med 1975; 17: 100-107.
34. Craswell PW. Chronic lead nephropathy. Annu Rev Med 1987; 38: 169-73.
35. Waldron HA. A note on the sensitivity of amethod used to detect lead in the eighteenth century. Br J Ind Med 1973; 30: 300.
36. Remini RV. Andrew Jackson and the Course of the American Freedom. New York: Harper & Row; 1981; 1822-32.
37. Deppisch LM, Centeno JA, Gemmel DJ, Torres NL. Andrew Jackson's exposure to mercury and lead: poisoned president? JAMA 1999; 287: 569-71.
38. Lin JL, Lin-Tan DT, Hsu KH, Yu CC. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med 2003; 348: 277-86.
39. Yu CC, Lin JL, Lin-Tan DT. Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. J Am Soc Nephrol 2004; 15: 1016-22.
40. Lin JL, Lin-Tan DT, Yu CC, Li YJ, Huang YY, Li KL. Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes. Kidney Int 2006; 69: 2049-56.